Bank of New York Mellon’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-44,720
| Closed | -$5.89M | – | 4398 |
|
|
2020
Q4 | $5.89M | Sell |
44,720
-2,052
| -4% | -$270K | ﹤0.01% | 2284 |
|
|
2020
Q3 | $2.36M | Buy |
46,772
+1,986
| +4% | +$100K | ﹤0.01% | 2571 |
|
|
2020
Q2 | $2.14M | Sell |
44,786
-11,792
| -21% | -$562K | ﹤0.01% | 2640 |
|
|
2020
Q1 | $2.77M | Buy |
56,578
+1,383
| +3% | +$67.8K | ﹤0.01% | 2371 |
|
|
2019
Q4 | $3.17M | Buy |
55,195
+11,957
| +28% | +$686K | ﹤0.01% | 2574 |
|
|
2019
Q3 | $1.56M | Sell |
43,238
-21,629
| -33% | -$778K | ﹤0.01% | 2892 |
|
|
2019
Q2 | $2.02M | Buy |
64,867
+18,933
| +41% | +$588K | ﹤0.01% | 2791 |
|
|
2019
Q1 | $1.08M | Buy |
45,934
+18,253
| +66% | +$428K | ﹤0.01% | 3120 |
|
|
2018
Q4 | $381K | Buy |
27,681
+13,991
| +102% | +$193K | ﹤0.01% | 3610 |
|
|
2018
Q3 | $137K | Buy |
+13,690
| New | +$137K | ﹤0.01% | 3982 |
|